[
    [
        {
            "time": "2021-01-28",
            "original_text": "泰格医药(300347.SZ)：2.56万股限制性股票已注销完成",
            "features": {
                "keywords": [
                    "泰格医药",
                    "限制性股票",
                    "注销"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泰格医药(300347.SZ)：2.56万股限制性股票已注销完成",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "泰格医药现1笔大宗交易 共成交241.39万元",
            "features": {
                "keywords": [
                    "泰格医药",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药现1笔大宗交易 共成交241.39万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-22",
            "original_text": "浙商证券 - 医药行业周报：CXO/IVD业绩预喜，疫情下持续高景气【行业研究】",
            "features": {
                "keywords": [
                    "CXO",
                    "IVD",
                    "业绩预喜",
                    "高景气"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券 - 医药行业周报：CXO/IVD业绩预喜，疫情下持续高景气【行业研究】",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "泰格医药预计2020年度归母净利润16.83亿元-18.1亿元 同比增逾1倍",
            "features": {
                "keywords": [
                    "泰格医药",
                    "归母净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药预计2020年度归母净利润16.83亿元-18.1亿元 同比增逾1倍",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "国盛证券 - 泰格医药：主营业务逐季恢复，看好长期快速发展【公司研究】",
            "features": {
                "keywords": [
                    "泰格医药",
                    "主营业务",
                    "恢复",
                    "长期发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券 - 泰格医药：主营业务逐季恢复，看好长期快速发展【公司研究】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "每日“药”闻|沃森生物业绩大增；泰格医药投资收益10亿元",
            "features": {
                "keywords": [
                    "泰格医药",
                    "投资收益",
                    "沃森生物",
                    "业绩大增"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "每日“药”闻|沃森生物业绩大增；泰格医药投资收益10亿元",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "浙商证券 - 泰格医药2020年业绩预告点评：符合预期，看好2021年加速趋势和国际拓展【公司研究】",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩预告",
                    "2021年",
                    "加速趋势",
                    "国际拓展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券 - 泰格医药2020年业绩预告点评：符合预期，看好2021年加速趋势和国际拓展【公司研究】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "[盈喜]泰格医药(03347-HK)料去年盈利倍增",
            "features": {
                "keywords": [
                    "泰格医药",
                    "盈喜",
                    "盈利倍增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[盈喜]泰格医药(03347-HK)料去年盈利倍增",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]